Table 1

Reactivity of proximal and distal segments and coronary stenoses to substance P and glyceryl trinitrate in patients with normal angiograms and in patients with stable angina

Minimum luminal diameter (mm)
Saline 1Substance P (5.6 pmol)Substance P (27.8 pmol)Saline 2Glyceryl trinitrate
Stable angina
Proximal (n = 50)3.10 (0.09) [0.7 (0.2)%]3.19 (0.10) [7.3 (1.4)%]3.28 (0.09) [7.9 (1.3)%]3.12 (0.09) [1.1 (0.2)%]3.35 (0.09) [10.2 (1.6)%]
 Distal (n = 59)1.35 (0.04) [1.0 (0.3)%]1.52 (0.05) [13.9 (1.9)%]1-150 1.54 (0.05) [16.1 (1.6)%]1-150 1.37 (0.04) [1.5 (0.3)%]1.64 (0.05) [21.5 (1.7)%]1-150
 Stenoses (n = 28)1.56 (0.08) [1.1 (0.3)%]1.68 (0.10) [9.6 (1.5)%]1.74 (0.10) [11.9 (1.8)%]1.58 (0.08) [1.4 (0.3)%]1.79 (0.10) [16.3 (1.8)%]1-160
Normal coronary arteries
Proximal (n = 19)3.03 (0.16) [0.4 (0.4)%]3.33 (0.16) [11.5 (2.3)%]3.43 (0.23) [15.0 (2.3)%]1-151 3.07 (0.16) [1.1 (0.4)%]3.53 (0.24) [18.4 (2.9)%]1-151
 Distal (n = 27)1.48 (0.04) [0.3 (0.5)%]1.68 (0.05) [14.5 (2.2)%]1.71 (0.05) [15.9 (1.6)%]1.50 (0.04) [0.9 (0.5)%]1.74 (0.06) [18.5 (2.7)%]
  • Values are mean (SEM); percentage change from baseline given in square brackets.

  • 1-150 p < 0.01 v proximal segments;

  • 1-151 p < 0.01v stable angina;

  • 1-160 p < 0.01v substance P responses.

  • Saline 1, first saline infusion; saline 2, second saline infusion.